Adrenal insufficiency detection in patients with immunoglobulin A nephropathy, lupus nephritis, and transplant recipients qualified for glucocorticoid withdrawal.
Chronic glucocorticoid (GC) therapy is the most common cause of secondary adrenal insufficiency (AI), which undiagnosed may lead to life-threatening adrenal crisis. Evaluation of AI in patients treated chronically with GCs, receiving a low maintenance dose (≤5mg of prednisone or equivalent): its prevalence and persistence, risk factors, and diagnostic accuracy of morning cortisol and dehydroepiandrosterone sulfate (DHEA-S). Adrenal function was evaluated in 40 patients before, after GC withdrawal and at least 1 year later. Based on morning cortisol and short Synacthen test (SST) patients were divided into three groups: AI, intermediate (partial AI) and AS (adrenal sufficiency). Receiver operator characteristic (ROC) curves were employed to assess the diagnostic value of morning cortisol and DHEA-S before GC withdrawal. Before GC withdrawal 42.5% of patients had AI or partial AI, which together persisted in 64.3% of them after withdrawal. After more than a year the adrenal function returned to normal only in 14% of patients. Cushingoid feature occurred more often in AI compared to AS group (60% vs 13%, P = 0.03). Morning cortisol ≥14.91 μg/dL (411 nmol/L) gave 100% negative predictive value (NPV) to rule-out AI. Morning cortisol ≤6.51 μg/dL (179.6 nmol/L) gave 100% positive predictive value (PPV) to rule-in AI. DHEA-S proved to be worse parameter for AI diagnosis. AI is common in patients treated with GCs and may persist for years after GC withdrawal. Cushingoid features are associated with a higher risk of AI. Morning cortisol may be helpful to facilitate AI diagnosis.